Inhibition of ZEB1 notably enhanced the tumor-suppressive effect of gemcitabine and prolonged overall survival (OS) in immunocompetent mice (Figure 1, C–E, and Supplemental Figure 1, O and P). The gene discussed is ZEB1; the disease is neoplasm.